147 related articles for article (PubMed ID: 9334899)
1. Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement.
Bourdon H; Trumpp-Kallmeyer S; Schreuder H; Hoflack J; Hibert M; Wermuth CG
J Comput Aided Mol Des; 1997 Jul; 11(4):317-32. PubMed ID: 9334899
[TBL] [Abstract][Full Text] [Related]
2. Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors.
Huang XP; Nagy PI; Williams FE; Peseckis SM; Messer WS
Br J Pharmacol; 1999 Feb; 126(3):735-45. PubMed ID: 10188986
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling of the interaction of diagnostic radiopharmaceuticals with receptor proteins: m2 antagonist binding to the muscarinic m2 subtype receptor.
Kapp OH; Siemion J; Eckelman WC; Cohen VI; Reba RC
Recept Signal Transduct; 1997; 7(3):177-201. PubMed ID: 9440504
[TBL] [Abstract][Full Text] [Related]
4. Antagonist binding in the rat muscarinic receptor A study by docking and X-ray crystallography.
Tanczos AC; Palmer RA; Potter BS; Saldanha JW; Howlin BJ
Comput Biol Chem; 2004 Dec; 28(5-6):375-85. PubMed ID: 15556478
[TBL] [Abstract][Full Text] [Related]
5. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
Peng JY; Vaidehi N; Hall SE; Goddard WA
ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
[TBL] [Abstract][Full Text] [Related]
6. Theoretical quantitative structure-activity relationship analysis on three dimensional models of ligand-m1 muscarinic receptor complexes.
Fanelli F; Menziani MC; Carotti A; De Benedetti PG
Bioorg Med Chem; 1994 Mar; 2(3):195-211. PubMed ID: 7922132
[TBL] [Abstract][Full Text] [Related]
7. Docking analyses on human muscarinic receptors: unveiling the subtypes peculiarities in agonists binding.
Vistoli G; Pedretti A; Dei S; Scapecchi S; Marconi C; Romanelli MN
Bioorg Med Chem; 2008 Mar; 16(6):3049-58. PubMed ID: 18182302
[TBL] [Abstract][Full Text] [Related]
8. Identification of a ligand-dependent switch within a muscarinic receptor.
Spalding TA; Burstein ES; Henderson SC; Ducote KR; Brann MR
J Biol Chem; 1998 Aug; 273(34):21563-8. PubMed ID: 9705286
[TBL] [Abstract][Full Text] [Related]
9. Enantiomeric N-methyl-4-piperidyl benzilates as muscarinic receptor ligands: Radioligand binding studies and docking studies to models of the three muscarinic receptors M1, M2 and M3.
Selent J; Brandt W; Pamperin D; Göber B
Bioorg Med Chem; 2006 Mar; 14(6):1729-36. PubMed ID: 16290166
[TBL] [Abstract][Full Text] [Related]
10. Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor.
Hamdan FF; Ward SD; Siddiqui NA; Bloodworth LM; Wess J
Biochemistry; 2002 Jun; 41(24):7647-58. PubMed ID: 12056896
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
[TBL] [Abstract][Full Text] [Related]
12. Structure and activation of muscarinic acetylcholine receptors.
Hulme EC; Lu ZL; Saldanha JW; Bee MS
Biochem Soc Trans; 2003 Feb; 31(Pt 1):29-34. PubMed ID: 12546648
[TBL] [Abstract][Full Text] [Related]
13. Constitutively active muscarinic receptors.
Spalding TA; Burstein ES
Life Sci; 2001 Apr; 68(22-23):2511-6. PubMed ID: 11392620
[TBL] [Abstract][Full Text] [Related]
14. Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site.
Heitz F; Holzwarth JA; Gies JP; Pruss RM; Trumpp-Kallmeyer S; Hibert MF; Guenet C
Eur J Pharmacol; 1999 Sep; 380(2-3):183-95. PubMed ID: 10513578
[TBL] [Abstract][Full Text] [Related]
15. Homology modeling of human muscarinic acetylcholine receptors.
Thomas T; McLean KC; McRobb FM; Manallack DT; Chalmers DK; Yuriev E
J Chem Inf Model; 2014 Jan; 54(1):243-53. PubMed ID: 24328076
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors.
Krajewski JL; Dickerson IM; Potter LT
Mol Pharmacol; 2001 Oct; 60(4):725-31. PubMed ID: 11562434
[TBL] [Abstract][Full Text] [Related]
17. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
Bissantz C; Bernard P; Hibert M; Rognan D
Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of human m1 muscarinic acetylcholine receptors with double mutations at the junction of TM VI and the third extracellular domain.
Huang XP; Williams FE; Peseckis SM; Messer WS
J Pharmacol Exp Ther; 1998 Sep; 286(3):1129-39. PubMed ID: 9732369
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C
Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131
[TBL] [Abstract][Full Text] [Related]
20. Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling.
Vogel WK; Sheehan DM; Schimerlik MI
Mol Pharmacol; 1997 Dec; 52(6):1087-94. PubMed ID: 9415719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
